Academic Journals Database
Disseminating quality controlled scientific knowledge

The Important Molecular Markers on Chromosome 17 and Their Clinical Impact in Breast Cancer

ADD TO MY LIST
 
Author(s): Wei Zhang | Yingyan Yu

Journal: International Journal of Molecular Sciences
ISSN 1422-0067

Volume: 12;
Issue: 9;
Start page: 5672;
Date: 2011;
Original page

Keywords: chromosome 17 | biomarkers | breast cancer

ABSTRACT
Abnormalities of chromosome 17 are important molecular genetic events in human breast cancers. Several famous oncogenes (HER2, TOP2A and TAU), tumor suppressor genes (p53, BRCA1 and HIC-1) or DNA double-strand break repair gene (RDM1) are located on chromosome 17. We searched the literature on HER2, TOP2A, TAU, RDM1, p53, BRCA1 and HIC-1 on the Pubmed database. The association of genes with chromosome 17, biological functions and potential significance are reviewed. In breast cancer, the polysomy 17 (three or more) is the predominant numerical aberration. HER2 amplification is widely utilized as molecular markers for trastuzumab target treatment. Amplified TOP2A, TAU and RDM1 genes are related to a significant response to anthracycline-based chemotherapy, taxane or cisplatin, respectively. In contrast, p53, BRCA1 and HIC-1 are important tumor suppressor genes related to breast carcinogenesis. This review focused on several crucial molecular markers residing on chromosome 17. The authors consider the somatic aberrations of chromosome 17 and associated genes in breast cancer.
Why do you need a reservation system?      Affiliate Program